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ABSTRACT: CD36 is an integral membrane protein which is thought to have a hairpin-like structure with alpha-helices at the C and N terminals projecting through the membrane as well as a larger extracellular loop. This receptor interacts with a number of ligands including oxidized low density lipoprotein
and long chain fatty acids (LCFAs). It is also implicated in lipid metabolism and heart diseases. It is therefore important to determine the 3D structure of the
CD36 site involved in lipid binding. In this study, we predict the 3D structure of the fatty acid (FA) binding site [127–279 aa] of the CD36 receptor based on
homology modeling with X-ray structure of Human Muscle Fatty Acid Binding Protein (PDB code: 1HMT). Qualitative and quantitative analysis of the
resulting model suggests that this model was reliable and stable, taking in consideration over 97.8% of the residues in the most favored regions as well as the
significant overall quality factor. Protein analysis, which relied on the secondary structure prediction of the target sequence and the comparison of 1HMT
and CD36 [127–279 aa] secondary structures, led to the determination of the amino acid sequence consensus. These results also led to the identification of
the functional sites on CD36 and revealed the presence of residues which may play a major role during ligand-protein interactions.
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Introduction

Long chain fatty acids (LCFAs) are an important source of
energy for the body. Disruption of their plasma concentration is a determining factor in the onset and development of
some diseases, mainly cardiovascular and metabolic ones. The
membrane transport, which is the first step toward LCFA
utilization consists of two components: diffusion “flip-flop”1
and protein facilitated transfer, such as CD36.2 The altered
expression of human CD36 is directly associated with dyslipidemia and the development of some cardiovascular diseases.
For example, the CD36 deficiency among Japanese population correlates with the development of hypertension, insulin
resistance, and an abnormal concentration of plasma lipids.3,4

CD36 polymorphisms were also shown to be correlated with
dyslipidemia and abnormal concentration of FAs in Caucasian populations.5 In vitro, lipid incorporation was altered in
muscle and adipose tissues of CD36-null mice and SHRs.6,7
CD36 is highly expressed in tissues that require energy
of FA oxidation, such as the heart and skeletal muscles.8,9
CD36 is also expressed in adipose tissue10 and in pneumocytes
characterized by the absorption of palmitic acid.11 CD36 is
most abundant in proximal segments and in villi enterocytes,
where most lipid absorption occurs.12 The tissue distribution
of CD36, and the research cited above, confirm the role of this
receptor in uptake and membrane transport of LCFAs. However, the non-resolution of the 3D structure of CD36 remains
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a large hurdle in expanding studies on this protein. The first
study to elucidate the CD36-FA binding site was done by
Baillie et al,13 suggesting a potential site by utilizing a simple
sequence alignment and without any validation.
The present study was designed to predict the 3D structure of CD36 [127–279 aa] based on homology modeling with
the FABP-H.

Methods

Sequence retrieval. The target sequence 127–279 of
CD36 was obtained from FASTA sequence of (CD36_
HUMAN) Platelet glycoprotein 4 with 472 amino acids (aa)
encoded by P16671 in Uniprot database.14
Template identification and sequence alignment.
The CD36 searched for similar sequence using the NCBI
BLAST15 (Basic Local Alignment Search Tool). This search
gave no significant results for the entire extracellular portion [30–440 aa] of CD36 as the binding site for FAs predicted [127–279 aa], reason why we decided to choose FABPs
(2FTB, 1FE3, 1HMT, 2FLJ, 1VYG, 1ADL, 1O8V, 1B56,
2IFB) (Table 1) which have the same characteristic to bind
LCFAs but showed alignment scores below 30%.
Human Muscle Fatty Acid Binding Protein (H-FABP)
with 133 aa (PDB code: 1HMT) binds several LCFAs, as
with the case of target sequences. The functional characteristics similarity between H-FABP and CD36 [127–279 aa], the
high-resolution of 1HMT with resolution value of 1.4 Å, and
the results of a study on reversible binding of LCFAs to purified fat, the adipose CD36 homolog,13 are the why 1HMT
was selected as a template.
Comparative modeling and structure refinement. The
theoretical structure of CD36-FA binding site of 1HMT was
generated using MODELLER-9v1116 by comparative modeling of protein structure prediction.
Table 1. Target protein and template protein considered for the study.
Target protein

Uniprot ID

Length

PDB ID

Fatty acid-binding
protein 2, liver

P81400

126 AA.

2FTB

Fatty acid-binding
protein, brain

O15540

132 AA.

1FE3

Fatty acid-binding
protein, heart

P05413

133 AA.

1HMS

Fatty acid-binding
protein, muscle

P41509

134 AA.

2FLJ

14 kDa Fatty acidbinding protein

P29498

133 AA.

1VYG

Fatty acid-binding
protein, adipocyte

P04117

132 AA.

1 ADL

Fatty acid-binding
protein homolog 1

Q02970

133 AA.

1O8V

Epidermal-typeFatty
acid-binding protein

Q01469

135 AA.

1B56

Fatty acid-binding
protein 2

P02693

132 AA.

2IFB
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MODELLER implements comparative protein structure
modeling by satisfaction of spatial restraints. The program was
designed to use as many different types of information about
the target sequence as possible.17 MODELLER generated
several preliminary models which were ranked based on their
DOPE scores. Several models with the lowest DOPE scores
were selected and the stereochemical properties of each one
were assessed by PROCHECK,18 and Errat.19 The model is
visualized by Discovery Studio Software.20
PROCHECK analysis of the model was performed
to determine whether the residues were falling in the most
favored region of the Ramachandran plot.21 The model with
the least number of residues in the disallowed region was
selected for further studies. Errat was used for verification of
evaluating the progress of crystallographic model building
and refinement.
Calculation of root mean square deviation (RMSD)
was performed by UCSF Chimera program. 22 It determines
the best-aligning pair of chains between template and match
structure.
Comparison between secondary structures of target/
template. Secondary structures of CD36 [127–279aa] and
1HMT were compared using UCSF Chimera program, which
gives the consensus sequence.
Prediction of secondary structure. PSIPRED, 23
BetaTPred2, 24 and GAMMAPRED25 servers were used to
predict the secondary structure of the target sequence, recognize helix, and strand and coil regions.
Expasy ProtParam server26 determined the percentage
of amino acid components essential for interpretation of the
predicted units of secondary structure.
Functional site prediction. Q-Sitefinder server27
was used to predict binding site residues in modeled target
sequences. Ten binding sites were predicted for the target
sequence. These binding sites were further compared to the
active sites of the template.
Pocket-Finder28 was used to compare pocket detection
with our ligand binding site detected by Q-sitefinder.

Results

Qualitative study of predicted model for CD36-FA
binding site. The generated model was confirmed using
NIH SAVeS (Structural Analysis and Verification Server)
(Fig. 1) and the accuracy was judged by PROCHECK analysis, which showed that 96.4% of the residues were found in
allowed regions of the Ramachandran Plot (Fig. 2). Among
the 138 residues, 128 residues were found in the most favored
region, 5 in the additionally allowed region, 2 in the generously allowed region, and 3 residues in the disallowed region
(Table 2).
Overall quality factor was calculated with Errat analysis
and the modeled structure was found to have 53.103% quality
factor. The RMSD between 102 atom pairs of predicted model
and template is 0.605 Å (Fig. 3).

3D structure prediction on receptor CD36
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Figure 1. Modeled structure of CD36 [127–279 aa] where α-helices
have been represented by red color, strands by cyan, loops in green
and the gray color indicates the coil.
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Secondary structure prediction. Table 3 shows the data
obtained from the Expasy’s ProtParam server, giving the percentage of amino acid components of the target sequence. The
high percentage of proline, glycine, aspartic acid, and asparagine in the CD36 [127–279 aa] demonstrates the dominance
of beta turns in this molecule compared with gamma turns,
which are clear in the results of BetaTPred2 and GammaPred
servers (Fig. 4).
PsiPred server revealed 19.6% residues in the formation
of two helices, 23.52% residues in six strands, and 56.88% residues in formed coils. Comparison of match CD36 [127–279
aa] and 1HMT shows a strong similarity of their secondary
structure, with the exception of a short part in the upstream,
the sequence length of beta sheets, and parts of gaps (Fig. 5).
Using the UCSF Chimera program, we were able to
determine 22 consensus residues between the matched CD36
[127–279 aa] and 1HMT (Fig. 5).
Determination of CD36 [127–279aa] active site. Among
the proposed sites obtained by Q-SiteFinder, and based on the
comparison of CD36 [127–279 aa] with the FA binding site of
1HMT, (CD36-S1) site was identified as: ALA143, SER146,
TYR149, GLN152, PHE153, LEU158, ILE162, ASN163,
LYS164, LYS166, SER167, SER168, PHE170, GLN171,
VAL172, THR174, ARG176, LEU189, PRO191, PRO193,
THR195, THR196, THR197, VAL198, TYR212, LYS213,
VAL214, PHE215, LYS218, ASP219, TYR238, GLU240,

ARG 51
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Figure 2. Ramachandran plot graphical.

SER253, PRO255, LEU264, PHE266, SER274, TYR276
(Fig. 6).
(CD36-S1 site) occupies a volume of 719 Å 3 with 5.16%
of the total volume of target sequence.
Pocket-Finder, which uses the same interface as
Q-SiteFinder, predicted that the site volume of the pocket has
1255 Å 3 with 9% of the total volume of the target sequence.
This site contains the same residues of (CD36-S1 site) and the
complementary residues that are crucial for the building of
the pocket.

Discussion

In this study, we determined the 3D model of CD36-FA
binding site. Qualitative analysis of the predicted model presented the best quality model, which was reliable as 97.8%
residues were in allowed regions according to Ramachandran

Table 2. Ramachandran plot calculations of CD36 [127–279 aa].
Ramachandran plot statistics

Modeled
sequence

% Amino acid in most favored regions

92.8

% Amino acid in additional allowed regions

3.6

% Amino acid in generously allowed regions

1.4

% Amino acid in disallowed regions

2.2

Figure 3. Superposed structure of Target (Tan) and Template (Cyan).
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Table 3. Percentage amino acids components of the target sequence.
Amino
acids

Ala
(A)

Arg
(R)

Asn
(N)

Asp
(D)

Cys
(C)

Gln
(Q)

Glu
(E)

Gly
(G)

His
(H)

Ile
(I)

Leu
(L)

Lys
(K)

Met
(M)

Phe
(F)

Pro
(P)

Ser
(S)

Thr
(T)

Trp
(W)

Tyr
(Y)

Val
(V)

%

6.5

3.3

7.2

5.2

1.3

3.9

2.9

4.6

1.3

5.9

7.8

5.2

2.0

7.2

3.9

9.8

5.9

1.3

5.9

9.2

plot statistics results. Errat analysis showed that the predicted
3D structure is stable, in addition to the high similarity in
the 3D structure determined by the RMSD of superimposed
template-target.
The secondary structure prediction, using Psipred, validated the target model based on their 2D structure.
The comparison between the predicted 2D structure
and that obtained by UCSF Chimera program confirm the
similarity of the 2D structure category in certain portions and
their location in the same position and was refer to by the helix
[140–164 aa] and the three strands [225–230 aa], [262–267
aa], and [273–279 aa]. According to the functional site prediction mentioned above, we were able to determine that these
six residues (Ser146, Ser168, Thr174, Leu189, Leu264, and
Tyr276) are involved in the formation of the active site.
In this paper, we were interested in the (CD36-S1) site,
which is probably the most active site for fixing LCFA. However, it is necessary to take into consideration the importance
of other active sites predicted in the interaction between
LCFA and CD36.
Recently, Kudal et al. showed that Lys164 of CD36 plays
a critical role in uptake of LCFAs.28 In our studies, and after
alignment analysis of the target and template, we were able
to show that Lys164 is semi-conserved (data not shown). On
the other hand, the position of Arg273 in the last strand suggests a role of this amino acid in CD36. We could conclude
that besides the six consensus residues mentioned above, the
Arg273 and Lys164, which are semi-conserved, are probably
involved in binding FAs by the CD36 protein.

Figure 4. (a) Predicted beta turn residues and (b) gamma turn residues
of CD36 [127–279 aa].
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In the generated model, two parts were detected. The
first one is composed of alpha-helices with hydrophobic
characteristics allowing a high affinity for LCFAs. This part
must be considered as the main portal of the CD36 receptor to
LCFAs. The second part is considered a central barrel where
all the functional sites predict by Q- Sitefinder are co-localizing. This part of CD36-FA binding site contains a cavity
which is characterized by the presence of a hydrophobic segment [184–204 aa] and is probably associated with the cell
membrane.29

Conclusion

This paper describes for the first time a 3D homology modeling
of transmembrane protein CD36 using a cytoplasmic protein
template. The 3D structure prediction of CD36-FA binding
site is a first step towards understanding the role played by
this receptor in lipid metabolism and development of different pathologies. The predicted functional sites and the precise
localization of the essential residues in LCFAs binding will
allow us to start docking analysis and confirm the precise role
of these CD36 residues in FA binding.
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